118 related articles for article (PubMed ID: 32763003)
1. [Pemetrexed-induced cutaneous sclerosis of the lower limbs].
Sarrazin M; Levavasseur M; Fadin A; Dezoteux F; Staumont-Sallé D
Ann Dermatol Venereol; 2020 Dec; 147(12):842-847. PubMed ID: 32763003
[TBL] [Abstract][Full Text] [Related]
2. [Pemetrexed-induced scleroderma-like changes in the lower legs].
Corbaux C; Marie J; Meraud JP; Lacroix S; Delhoume JY; Jouary T; Madoui S
Ann Dermatol Venereol; 2015 Feb; 142(2):115-20. PubMed ID: 25554663
[TBL] [Abstract][Full Text] [Related]
3. PEMETREXED-INDUCED PSEUDOCELLULITIS - A RARE CUTANEOUS ADVERSE REACTION TO MULTI-TARGETED ANTIFOLATE THERAPY.
Wollina U; Hansel G; Zschuppe E; Tchernev G
Georgian Med News; 2017 Jun; (267):81-84. PubMed ID: 28745612
[TBL] [Abstract][Full Text] [Related]
4. Incidence of cutaneous reactions with pemetrexed: Comparison of patients who received three days of oral dexamethasone twice daily to patients who did not.
Clark SK; Anselmo LM
J Oncol Pharm Pract; 2019 Oct; 25(7):1645-1650. PubMed ID: 30319062
[TBL] [Abstract][Full Text] [Related]
5. Renal damage induced by pemetrexed causing drug discontinuation: a case report and review of the literature.
Sbitti Y; Chahdi H; Slimani K; Debbagh A; Mokhlis A; Albouzidi A; Bennani F; Errihani H; Ichou M
J Med Case Rep; 2017 Jul; 11(1):182. PubMed ID: 28750665
[TBL] [Abstract][Full Text] [Related]
6. Single-dose dexamethasone for the prevention of pemetrexed associated cutaneous adverse reactions.
Elsoueidi R; Lander MJ; Richa EM; Adane ED
J Oncol Pharm Pract; 2016 Apr; 22(2):271-4. PubMed ID: 25908647
[TBL] [Abstract][Full Text] [Related]
7. Unusually prolonged pemetrexed cytotoxicity in a patient with a lung adenocarcinoma: a case report.
Sakhri L; Pinsolle J; Moro-Sibilot D; Pluchart H
J Med Case Rep; 2017 Sep; 11(1):262. PubMed ID: 28915906
[TBL] [Abstract][Full Text] [Related]
8. Eyelid and feet edema induced by pemetrexed.
Kastalli S; Charfi O; Sahnoun R; Lakhoua G
Indian J Pharmacol; 2016; 48(6):741-742. PubMed ID: 28066120
[TBL] [Abstract][Full Text] [Related]
9. Skin toxicities compromise prolonged pemetrexed treatment.
Eguia B; Ruppert AM; Fillon J; Lavolé A; Gounant V; Epaud C; Milleron B; Moguelet P; Wislez M; Frances C; Cadranel J
J Thorac Oncol; 2011 Dec; 6(12):2083-9. PubMed ID: 21892100
[TBL] [Abstract][Full Text] [Related]
10. Pemetrexed-Induced Pseudocellulitis Reaction With Eosinophilic Infiltrate on Skin Biopsy.
Tracey EH; Modi B; Micheletti RG
Am J Dermatopathol; 2017 Jan; 39(1):e1-e2. PubMed ID: 27415636
[TBL] [Abstract][Full Text] [Related]
11. Pemetrexed-induced eyelid edema in lung cancer.
Martins-Filho PR; Kameo SY; Mascarenhas-Oliveira AC; Vieira NF; Azevedo E
J Craniofac Surg; 2013 Jul; 24(4):e401-3. PubMed ID: 23851735
[TBL] [Abstract][Full Text] [Related]
12. Pemetrexed-induced Sweet Syndrome: First case report in the medical literature.
Korkmaz M; Eryılmaz MK; Karaağaç M; Demirkıran A; Araz M; Artaç M
J Oncol Pharm Pract; 2021 Jul; 27(5):1307-1310. PubMed ID: 33028131
[TBL] [Abstract][Full Text] [Related]
13. Pemetrexed-induced acute kidney injury leading to chronic kidney disease.
Chauvet S; Courbebaisse M; Ronco P; Plaisier E
Clin Nephrol; 2014 Dec; 82(6):402-6. PubMed ID: 24424085
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy-induced cardiomyopathy caused by Pemetrexed.
Oyakawa T; Iida K; Kusuhara M; Kenmotsu H; Sugino T
Invest New Drugs; 2018 Feb; 36(1):147-150. PubMed ID: 28660548
[TBL] [Abstract][Full Text] [Related]
15. Comparison between two premedication regimens of dexamethasone before a pemetrexed-based chemotherapy: A single-center experience study.
Groleau A; Côté J
J Oncol Pharm Pract; 2020 Apr; 26(3):612-618. PubMed ID: 31370748
[TBL] [Abstract][Full Text] [Related]
16. [Pemetrexed-induced eyelid edema].
Badaoui A; Mahé E
Ann Dermatol Venereol; 2018 Dec; 145(12):769-772. PubMed ID: 30297200
[TBL] [Abstract][Full Text] [Related]
17. Aplastic anemia in a lung adenocarcinoma patient receiving pemetrexed.
Matama G; Tokito T; Takeoka H; Hiraoka Y; Matsuo N; Nakamura M; Ishii H; Kinoshita T; Azuma K; Yamada K; Hoshino T
Invest New Drugs; 2017 Oct; 35(5):662-664. PubMed ID: 28361276
[TBL] [Abstract][Full Text] [Related]
18. Pemetrexed-induced lower limb pseudocellulitis.
Liau MM; Santosa A; Huang J; Tan LC
Clin Exp Dermatol; 2017 Dec; 42(8):914-916. PubMed ID: 28815694
[No Abstract] [Full Text] [Related]
19. Posterior reversible encephalopathy syndrome possibly induced by pemetrexed maintenance therapy for lung cancer: a case report and literature review.
Smets GJ; Loyson T; Van Paesschen W; Demaerel P; Nackaerts K
Acta Clin Belg; 2018 Oct; 73(5):382-388. PubMed ID: 29173113
[TBL] [Abstract][Full Text] [Related]
20. Pemetrexed-Induced Rash May Be Prevented by Supplementary Corticosteroids.
Sakurada T; Kakiuchi S; Tajima S; Horinouchi Y; Konaka K; Okada N; Nishisako H; Nakamura T; Teraoka K; Kawazoe K; Yanagawa H; Nishioka Y; Ishizawa K
Biol Pharm Bull; 2015; 38(11):1752-6. PubMed ID: 26521826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
